Further experiments confirmed that CD4 depletion either prior to surgery, or during vaccination was sufficient to eradicate tumor in 50% (5/10) of treated animals and this could be increased to 70% (7/10) when vaccination was combined with surgery (Figure 2B), demonstrating that vaccination with CD4 depletion significantly enhances survival compared to surgery alone. This evidence concerns the gene CD4 and neoplasm.